Last reviewed · How we verify
Physician's choice of chemotherapy. — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Physician's choice of chemotherapy. (Physician's choice of chemotherapy.) — MacroGenics. This is a placeholder term referring to standard chemotherapy regimens selected by the treating physician, rather than a specific drug entity.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Physician's choice of chemotherapy. TARGET | Physician's choice of chemotherapy. | MacroGenics | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Physician's choice of chemotherapy. CI watch — RSS
- Physician's choice of chemotherapy. CI watch — Atom
- Physician's choice of chemotherapy. CI watch — JSON
- Physician's choice of chemotherapy. alone — RSS
Cite this brief
Drug Landscape (2026). Physician's choice of chemotherapy. — Competitive Intelligence Brief. https://druglandscape.com/ci/physician-s-choice-of-chemotherapy. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab